Back
Inhibikase Therapeutics, Inc. IKT · Insights
Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops ther... Price1.68
Market Cap234.42 M
Float111.9 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro